Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSPC PHARMA

5.980
-0.170-2.76%
Volume:107.83M
Turnover:654.26M
Market Cap:69.03B
PE:15.25
High:6.190
Open:6.060
Low:5.960
Close:6.150
Loading ...

BRIEF-CSPC Pharmaceutical Says SYH2062 Injection Approved To Conduct Clinical Trials In China

Reuters
·
23 Dec 2024

CSPC Pharmaceutical - Syh2062 Injection Approved by Nmpa to Conduct Clinical Trials in China

THOMSON REUTERS
·
23 Dec 2024

CSPC Pharmaceutical Gets Clinical Trial Go-Ahead for Tumor Drug in China

MT Newswires Live
·
20 Dec 2024

CSPC Pharmaceutical Gets China Nod for Clinical Trial of Cancer Drug

MT Newswires Live
·
20 Dec 2024

CSPC Pharmaceutical Says Semaglutide Long-Acting Injection Obtains Clinical Trial Approval

Reuters
·
20 Dec 2024

BRIEF-CSPC Pharmaceutical Obtains Clinical Trial Approval For SYS6043 (Antibody-Drug Conjugate) From NMPA

Reuters
·
20 Dec 2024

CSPC Pharmaceutical - Sys6005 (Antibody-Drug Conjugate) Obtains Clinical Trial Approval From Nmpa

THOMSON REUTERS
·
20 Dec 2024

CSPC Pharmaceutical - Approval Granted by China's Nmpa

THOMSON REUTERS
·
20 Dec 2024

CSPC Pharmaceutical - Semaglutide Long-Acting Injection (Syh9017) Obtains Clinical Trial Approval

THOMSON REUTERS
·
20 Dec 2024

CSPC Pharmaceutical Group Grants Exclusive License of Cancer Inhibitor to BeiGene Switzerland

MT Newswires Live
·
13 Dec 2024

BRIEF-CSPC Pharmaceutical Announces Exclusive License Agreement For SYH2039 With Beigene

Reuters
·
13 Dec 2024

CSPC Pharmaceutical - Exclusive License Agreement for Syh2039 With Beigene

THOMSON REUTERS
·
13 Dec 2024

China Healthcare Sector's Recovery Momentum May Continue in 2025 -- Market Talk

Dow Jones
·
10 Dec 2024

CSPC Pharmaceutical Unit Gets Chinese Drug Regulator's Marketing Approval for Breast Cancer Drug

MT Newswires Live
·
09 Dec 2024

BRIEF-Cspc Pharmaceutical Says Syhx2011 Received Marketing Approval By Nmpa

Reuters
·
09 Dec 2024

CSPC Pharmaceutical - Acceptance of Application for Marketing Approval of Syhx2011 by Nmpa

THOMSON REUTERS
·
09 Dec 2024

CSPC Pharmaceutical - Chen Weiping Appointed as an Executive Director

THOMSON REUTERS
·
06 Dec 2024

Retail investors who have a significant stake must be disappointed along with institutions after CSPC Pharmaceutical Group Limited's (HKG:1093) market cap dropped by HK$2.3b

Simply Wall St.
·
05 Dec 2024

CSPC Pharmaceutical Group's Cervical Cancer Drug Gets FDA's 'Fast Track' Designation

MT Newswires Live
·
04 Dec 2024

BRIEF-Cspc Pharmaceutical Says Tedizolid Phosphate Tablets Obtains Drug Registration Approval

Reuters
·
04 Dec 2024